Ligand Pharmaceuticals Incorporated · NASDAQ:LGND
Kozarich John W sold 2,501 Ligand Pharmaceuticals Incorporated shares (Form 4)
Traded May 1 to May 13, 2026 · Filed May 14, 2026
From May 1 to May 13, 2026, Kozarich John W (Director) sold 2,501 Ligand Pharmaceuticals Incorporated shares at an average US$225.14 for US$563K under a trading plan, leaving 41,786 shares. Filed May 14, 2026 (Form 4).
- Sold
- 2,501 shares
- Price
- US$225.14 average (US$223.50 to US$234.09)
- Value
- US$563K
- Holding after
- 41,786 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 1, 2026 | Common Stock | Sale | 80 | US$227.37 | 42,173 | Direct |
| May 1, 2026 | Common Stock | Sale | 1 | US$229.87 | 42,172 | Direct |
| May 1, 2026 | Common Stock | Sale | 165 | US$231.87 | 42,007 | Direct |
| May 1, 2026 | Common Stock | Sale | 105 | US$232.57 | 41,902 | Direct |
| May 1, 2026 | Common Stock | Sale | 116 | US$234.09 | 41,786 | Direct |
| May 12, 2026 | Common Stock | Option exercise | 459 | US$69.51 | 42,245 | Direct |
| May 12, 2026 | Common Stock | Sale | 459 | US$224.00 | 41,786 | Direct |
| May 13, 2026 | Common Stock | Option exercise | 1,575 | US$69.51 | 43,361 | Direct |
| May 13, 2026 | Common Stock | Sale | 1,575 | US$223.50 | 41,786 | Direct |
Source
Related
- Ligand Pharmaceuticals Incorporated
- Kozarich John W
- Ligand Pharmaceuticals Incorporated shareholders
- Form 4 · Kozarich John W · Jun 9, 2026
- Form 4 · Kozarich John W · Apr 2, 2026
- Form 4 · Reardon Andrew · Oct 6, 2026
- Form 4 · Zimmermann Martine · Sep 24, 2026
- Form 4 · Zimmermann Martine · Sep 14, 2026
- Form 4 · Reardon Andrew · Sep 8, 2026
- Form 4 · Espinoza Octavio · Aug 14, 2026